c="inositol hexaphosphate" 1:4 1:5||t="medication"||cui="C0031855"||tot="Phytic Acid"||ns="-1000"
c="high oxygen affinity hemoglobin" 2:9 2:12||t="problem"||cui="C0272154"||tot="High oxygen affinity hemoglobin polycythemia"||ns="-1000"
c="examined" 2:18 2:18||t="problem"||cui="C0332128"||tot="Examined"||ns="-1000"
c="its nitric oxide liganded form" 2:20 2:24||t="treatment"||cui="C0013058"||tot="Dosage Form"||ns="-812"
c="examined" 2:40 2:40||t="problem"||cui="C0332128"||tot="Examined"||ns="-1000"
c="inositol hexaphosphate induced transition" 2:58 2:61||t="problem"||cui="C1705165"||tot="Nucleotide Transition Abnormality"||ns="-812"
c="inositol hexaphosphate (IHP" 2:70 2:72||t="medication"||cui="C0031855"||tot="Phytic Acid"||ns="-1000"
c="electron paramagnetic resonance (EPR" 2:104 2:107||t="test"||cui="C0013845"||tot="Electron Spin Resonance Spectroscopy"||ns="-1000"
